Caricamento...
Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
Diabetic macular oedema (DMO) is one of the leading causes of vision loss associated with diabetic retinopathy (DR). New insights in managing this condition have changed the paradigm in its treatment, with intravitreal injections of antivascular endothelial growth factor (anti-VEGF) having become th...
Salvato in:
| Pubblicato in: | Cells |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8307715/ https://ncbi.nlm.nih.gov/pubmed/34359853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10071683 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|